Michael Altman

Michael Altman

Founder chez ARYA SCIENCES ACQUISITION CORP IV

Fortune : 487 628 $ au 31/03/2024

42 ans
Finance
Health Technology
Health Services

Profil

Michael R.
Altman
is the founder of ARYA Sciences Acquisition Corp.
(founded in 2018), ARYA Sciences Acquisition Corp.
II (founded in 2020), ARYA Sciences Acquisition Corp.
III (founded in 2020), ARYA Sciences Acquisition Corp.
IV (founded in 2020), and ARYA Sciences Acquisition Corp.
V (founded in 2021).
He held the title of Chief Financial Officer & Director at each of these companies.
He currently holds the position of Managing Director at Perceptive Advisors LLC (since 2007), Director at Vitruvias Therapeutics, Inc. (since 2017), Independent Director at Lyra Therapeutics, Inc. (since 2018), Managing Director at Perceptive Advisors (Private Equity) (since 2007), Director at Covid Apollo Project LLC, and Independent Director at Nautilus Biotechnology, Inc. (since 2021).
His former positions include Director at Vensun Pharmaceuticals, Inc. (2016-2019), Healthcare Analyst at First New York Securities LLC (2007), and Vice President at Mako Merger Sub, Inc.Mr. Altman obtained his undergraduate degree from the University of Vermont in 2004.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/02/2024 165 860 ( 0,13% ) 487 628 $ 31/03/2024
01/03/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Michael Altman

SociétésPosteDébut
LYRA THERAPEUTICS, INC. Director/Board Member 01/06/2018
ARYA SCIENCES ACQUISITION CORP IV Founder 24/08/2020
NAUTILUS BIOTECHNOLOGY, INC. Director/Board Member 09/06/2021
ARYA SCIENCES ACQUISITION CORP V Founder 22/02/2021
Analyst-Fixed Income 01/10/2007
Director/Board Member -
Private Equity Analyst 01/01/2007
Director/Board Member -
Tous les postes actifs de Michael Altman

Anciens postes connus de Michael Altman

SociétésPosteFin
ARYA SCIENCES ACQUISITION III A Founder 01/06/2021
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░ ░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Michael Altman

Formation de Michael Altman

University of Vermont Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael Altman

Relations

100 +

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
LYRA THERAPEUTICS, INC.

Health Technology

ARYA SCIENCES ACQUISITION CORP IV

Finance

NAUTILUS BIOTECHNOLOGY, INC.

Health Technology

Entreprise privées11

Finance

Health Technology

Health Services

Finance

Finance

Finance

Finance

Finance

Finance

Mako Merger Sub, Inc.

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Michael Altman